GENEVA (Reuters) - Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information. The World Health Organization, which hosted a meeting of national regulatory authorities and ethics committees earlier this week, said they had thoroughly discussed all aspects of the proposed trials at the two-day meeting. ...
via Health News Headlines - Yahoo News http://ift.tt/1z2SGSE
No comments:
Post a Comment